biostudies-literatureUnknown20(1)Baquedano L<h4>Objective</h4>To study what women think about menopause treatments and assess their knowledge about them. To analyze adherence to treatment during COVID-19 confinement as a secondary objective.<h4>Methods</h4>A multi-center cross-sectional observational study was conducted using a survey of 2500 women between January and June 2019. This was administered following a non-probability sampling procedure including women between 35 and 75 years. An extension study was conducted during the coronavirus pandemic, between March and June 2020.<h4>Results</h4>The responses of 2355 surveyed women were analyzed. Of this sample, 42% knew about menopause hormone therapy (MHT). The most frequently identified indication was the treatment of hot flashes (65.6%). The MHT risks most frequently perceived weBMC women's health277https://www.ebi.ac.uk/biostudies/studies/S-EPMC7768270biostudies-literatureBeliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM-treatment study.PMC7768270Baquedano LGabasa LCholiz MPresa JMendoza NBorque ARoy VYague HCoronado PJLlaneza PFasero MCOMEM Study Spanish investigatorsRubio PPalacios SNegredo ISanchez-Borrego RRuiz LVillalobos FColmenarejo FLamarca MDel Tiempo PGutierrez LHernnandez MDieste PRamirez IJose YEspiau ACotaina LOrtega SPuente MJAznar TTajada PDJurado ARfalseBeliefs, knowledge and the impact of COVID19 on menopause therapies in Spanish women: COMEM-treatment study.<h4>Objective</h4>To study what women think about menopause treatments and assess their knowledge about them. To analyze adherence to treatment during COVID-19 confinement as a secondary objective.<h4>Methods</h4>A multi-center cross-sectional observational study was conducted using a survey of 2500 women between January and June 2019. This was administered following a non-probability sampling procedure including women between 35 and 75 years. An extension study was conducted during the coronavirus pandemic, between March and June 2020.<h4>Results</h4>The responses of 2355 surveyed women were analyzed. Of this sample, 42% knew about menopause hormone therapy (MHT). The most frequently identified indication was the treatment of hot flashes (65.6%). The MHT risks most frequently perceived we2020-01-01T00:00:00Z2020 Dec2025-04-19T08:16:28.353Z2021-02-20T17:15:05ZS-EPMC77682703337188310.1186/s12905-020-01151-x